Matches in Nanopublications for { ?s ?p "[Specifically, siRNA-mediated inhibition of Cdk9 caused a shift from G 0/G 1 to G 2/M phase in human PC3 prostate cancer cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[Specifically, siRNA-mediated inhibition of Cdk9 caused a shift from G 0/G 1 to G 2/M phase in human PC3 prostate cancer cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Specifically, siRNA-mediated inhibition of Cdk9 caused a shift from G 0/G 1 to G 2/M phase in human PC3 prostate cancer cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP302170.RAe1rCd85oJ5akKHwWhRBwEHisSCcDx_oVHLD1KngqH4Y130_assertion description "[Specifically, siRNA-mediated inhibition of Cdk9 caused a shift from G 0/G 1 to G 2/M phase in human PC3 prostate cancer cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP302170.RAe1rCd85oJ5akKHwWhRBwEHisSCcDx_oVHLD1KngqH4Y130_provenance.
- NP965515.RASxZCZHyjofaoAW5MhFMQd-DeFdbdEKgJr7oKeygVvFM130_assertion description "[Specifically, siRNA-mediated inhibition of Cdk9 caused a shift from G 0/G 1 to G 2/M phase in human PC3 prostate cancer cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP965515.RASxZCZHyjofaoAW5MhFMQd-DeFdbdEKgJr7oKeygVvFM130_provenance.
- NP302173.RAtN3_HwgpEADzChXx6JQYe0KbptYRPYqtv5d8snzUPqE130_assertion description "[Specifically, siRNA-mediated inhibition of Cdk9 caused a shift from G 0/G 1 to G 2/M phase in human PC3 prostate cancer cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP302173.RAtN3_HwgpEADzChXx6JQYe0KbptYRPYqtv5d8snzUPqE130_provenance.
- NP965516.RA6WO9kcVsJvPu0su1dLkoDc_6htW5pIaJistcWoxM6AI130_assertion description "[Specifically, siRNA-mediated inhibition of Cdk9 caused a shift from G 0/G 1 to G 2/M phase in human PC3 prostate cancer cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP965516.RA6WO9kcVsJvPu0su1dLkoDc_6htW5pIaJistcWoxM6AI130_provenance.